{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:31:36Z","timestamp":1793428296235,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Salivary cortisol has the advantages of being noninvasive, readily accessible in ambulatory patients and reflecting the free bioactive fraction of cortisol. The cortisol diurnal cycle, based on 6 samples collected every 4\u2005h over a 24-h period, allows a detailed characterization of cortisol variations throughout the day. The objective of this study was to assess the value of the salivary cortisol diurnal cycle for the diagnosis of Cushing's syndrome (CS) and the differential diagnosis of nonneoplastic hypercortisolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This retrospective cohort study included all the patients hospitalized in Endocrinology department of Cochin Hospital between 2012 and 2018 who had complete serum and salivary diurnal cycle assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum and salivary cortisol levels were measured using an automated and a radio immunoassay, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 227 subjects without CS, 46 patients with nonneoplastic CS, 72 patients with ACTH-dependent CS, and 67 with adrenal CS were included. For the diagnosis of CS, the cortisol nadir throughout the day showed better diagnostic performance than midnight cortisol, both in serum and saliva with, area under the receiver operating characteristic curves (ROC AUCs) of 0.98 and of 0.96, respectively. For the differential diagnosis between nonneoplastic hypercortisolism and ACTH-dependent CS, salivary cortisol showed better diagnostic performance than midnight serum cortisol (ROC AUC 0.97; optimal cutoff 5.3\u2005nM; sensitivity 90%; and specificity 87% for the salivary cortisol nadir).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The salivary cortisol diurnal cycle appears to be a powerful tool for the diagnosis of CS and for the challenging differential diagnosis of nonneoplastic hypercortisolism, with the major advantage of being accessible in ambulatory patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag192","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:49:41Z","timestamp":1791978581000},"page":"667-676","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic utility of diurnal salivary cortisol profiles in neoplastic and nonneoplastic hypercortisolism"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-8807","authenticated-orcid":false,"given":"Fid\u00e9line","family":"Bonnet-Serrano","sequence":"first","affiliation":[{"name":"Hormonology Department, Cochin Hospital , 75014 Paris ,","place":["France"]},{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-1247","authenticated-orcid":false,"given":"Jonathan","family":"Poirier","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"El Khoury","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6308-3309","authenticated-orcid":false,"given":"Louis","family":"Thomeret","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2758-5500","authenticated-orcid":false,"given":"Nesrine","family":"Benanteur","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-2065","authenticated-orcid":false,"given":"Anne","family":"Jouinot","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Cl\u00e9mence","family":"Leguy","sequence":"additional","affiliation":[{"name":"Hormonology Department, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vaczlavik","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-1598","authenticated-orcid":false,"given":"Lucas","family":"Bouys","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2782-5750","authenticated-orcid":false,"given":"Laurence","family":"Guignat","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-475X","authenticated-orcid":false,"given":"Lionel","family":"Groussin","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-0906","authenticated-orcid":false,"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Guibourdenche","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3008","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[{"name":"Team \u00ab Genomic and Signaling of Endocrine Tumors \u00bb, Institut Cochin, INSERM U1016- CNRS UMR8104-Universit\u00e9 Paris-Cit\u00e9 , 75014 Paris ,","place":["France"]},{"name":"Endocrinology Department, Reference Center for Rare Adrenal Diseases, Cochin Hospital , 75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"18","key":"2026103101412712900_lvag192-B1","doi-asserted-by":"publisher","first-page":"9141","DOI":"10.3390\/ijms26189141","article-title":"Cortisol detection methods and the Hormone's role in evaluating circadian rhythm disruption","volume":"26","author":"Juliana","year":"2025","journal-title":"Int J Mol Sci."},{"issue":"701","key":"2026103101412712900_lvag192-B2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg8464","article-title":"High-resolution daily profiles of tissue adrenal steroids by portable automated collection","volume":"15","author":"Upton","year":"2023","journal-title":"Sci Transl Med."},{"issue":"4","key":"2026103101412712900_lvag192-B3","doi-asserted-by":"publisher","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing's syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2026103101412712900_lvag192-B4","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2026103101412712900_lvag192-B5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"2026103101412712900_lvag192-B6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2026103101412712900_lvag192-B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cen.14014","article-title":"The incidence of endogenous Cushing's syndrome in the modern era","volume":"91","author":"Wengander","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8014","key":"2026103101412712900_lvag192-B8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(77)92169-9","article-title":"Alcohol-induced pseudo-Cushing's syndrome","volume":"1","author":"Rees","year":"1977","journal-title":"Lancet"},{"issue":"5","key":"2026103101412712900_lvag192-B9","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-16-0946","article-title":"Diagnosis of endocrine disease: differentiation of pathologic\/neoplastic hypercortisolism (Cushing's syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2026103101412712900_lvag192-B10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ando.2018.04.017","article-title":"The difficulties of pseudo-Cushing's syndrome (or \"non-neoplastic hypercortisolism\")","volume":"79","author":"Chabre","year":"2018","journal-title":"Ann Endocrinol (Paris)."},{"issue":"5","key":"2026103101412712900_lvag192-B11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2026103101412712900_lvag192-B12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2026103101412712900_lvag192-B13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ando.2022.02.001","article-title":"Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome","volume":"83","author":"Tabarin","year":"2022","journal-title":"Ann Endocrinol (Paris)."},{"issue":"6","key":"2026103101412712900_lvag192-B14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1210\/clinem\/dgag095","article-title":"Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement","volume":"111","author":"Hamidi","year":"2026","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2026103101412712900_lvag192-B15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/jcem-25-8-1057","article-title":"Effects of estrogen therapy on cortisol metabolism","volume":"25","author":"Grant","year":"1965","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026103101412712900_lvag192-B16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/00365513.2019.1622031","article-title":"New reference intervals for cortisol, cortisol binding globulin and free cortisol index in women using ethinyl estradiol","volume":"79","author":"Panton","year":"2019","journal-title":"Scand J Clin Lab Invest."},{"issue":"5","key":"2026103101412712900_lvag192-B17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-2265.2007.02784.x","article-title":"The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol","volume":"66","author":"Qureshi","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2026103101412712900_lvag192-B18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1210\/jcem-66-2-343","article-title":"Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function","volume":"66","author":"Laudat","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2026103101412712900_lvag192-B19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ncpendmet0837","article-title":"Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome","volume":"4","author":"Carroll","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab."},{"issue":"1","key":"2026103101412712900_lvag192-B20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0009-8981(85)90232-3","article-title":"Salivary cortisol for the evaluation of Cushing's syndrome","volume":"151","author":"Luthold","year":"1985","journal-title":"Clin Chim Acta."},{"issue":"3","key":"2026103101412712900_lvag192-B21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12020-012-9597-z","article-title":"Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system","volume":"41","author":"Carrasco","year":"2012","journal-title":"Endocrine"},{"issue":"1","key":"2026103101412712900_lvag192-B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ando.2023.10.007","article-title":"Diagnostic performance of an automated immunoassay for salivary cortisol","volume":"85","author":"Laguillier-Morizot","year":"2024","journal-title":"Ann Endocrinol (Paris)."},{"issue":"10","key":"2026103101412712900_lvag192-B23","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1515\/cclm-2023-0141","article-title":"Salivary cortisol and cortisone in diagnosis of Cushing's syndrome\u2014a comparison of six different analytical methods","volume":"61","author":"B\u00e4cklund","year":"2023","journal-title":"Clin Chem Lab Med."},{"issue":"12","key":"2026103101412712900_lvag192-B24","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1515\/cclm-2016-1100","article-title":"Influence of age, gender and body mass index on late-night salivary cortisol in healthy adults","volume":"55","author":"Coelli","year":"2017","journal-title":"Clin Chem Lab Med."},{"key":"2026103101412712900_lvag192-B25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinbiochem.2021.11.016","article-title":"Novel threshold value of midnight serum cortisol for diagnosis of hypercortisolism using the Roche Cortisol II assay","volume":"101","author":"Noel","year":"2022","journal-title":"Clin Biochem."},{"issue":"11","key":"2026103101412712900_lvag192-B26","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1515\/cclm-2025-0133","article-title":"Performance of afternoon (16:00\u202fh) serum cortisol for the diagnosis of Cushing's syndrome","volume":"63","author":"Dupuis","year":"2025","journal-title":"Clin Chem Lab Med."},{"issue":"7","key":"2026103101412712900_lvag192-B27","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1210\/jc.2003-031790","article-title":"Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes","volume":"89","author":"Yaneva","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2026103101412712900_lvag192-B28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.amjmed.2025.04.035","article-title":"The combination of afternoon and midnight salivary cortisol improves the diagnosis of Cushing\u2019s syndrome","volume":"138","author":"Lionetto","year":"2025","journal-title":"Am J Med."},{"issue":"3","key":"2026103101412712900_lvag192-B29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1210\/jcem.84.3.5521","article-title":"Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests","volume":"84","author":"Castro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2026103101412712900_lvag192-B30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-13-0702","article-title":"Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests","volume":"170","author":"Alwani","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2026103101412712900_lvag192-B31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2265.2012.04508.x","article-title":"Measurement of salivary cortisol in 2012\u2014laboratory techniques and clinical indications","volume":"77","author":"Inder","year":"2012","journal-title":"Clin Endocrinol (Oxf)."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag192\/71957455\/lvag192.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/667\/71957455\/lvag192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/667\/71957455\/lvag192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:41:31Z","timestamp":1793425291000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/4\/667\/8916840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag192","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10]]}}}